Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized 3% Hypertonic Saline in Bronchiolitis
NCT02834819Terminated
- Sponsor
- University of Colorado Denver
- Start
- Sep 2013
- Primary completion
- Sep 2015
- Modality
- Small Molecules, Device-based Delivery
01
Overview
Randomised, single-blind trial of hypertonic saline in bronchiolitis (2 arms), sponsored by University of Colorado Denver. Primary endpoints: Hospitalization Rate at 7 days, Number of Patients With Persistent Hypoxia at 90 minutes and 1 more. Started Sep 2013; status: terminated.
02
Drugs
hypertonic saline
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on NCT02834819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02834819.